Is semaglutide safe for weight loss? For appropriate patients, semaglutide can be used as part of a medically supervised weight-management plan, but it is not right for everyone. Potential benefits, side effects, and individual health risks should be reviewed with a qualified healthcare provider. Obesity affects about 40% of U.S. adults, and GLP-1 medications have become an important treatment option for some patients. Below, we explain how semaglutide works, what research shows about weight loss, and the safety considerations to discuss with your provider.
How Does Semaglutide Work for Weight Loss?
Semaglutide is a GLP-1 receptor agonist that mimics a naturally occurring hormone involved in appetite regulation and calorie intake. By activating GLP-1 receptors, semaglutide can help reduce hunger, increase feelings of fullness, and decrease overall calorie intake. It may also slow gastric emptying and influence blood sugar regulation. When prescribed for weight management, semaglutide is intended to be used alongside nutrition, physical activity, and ongoing medical supervision.
How Effective Is Semaglutide for Weight Loss?
Clinical research has shown that semaglutide can produce meaningful weight loss in appropriate patients when combined with lifestyle changes. In the STEP 1 clinical trial, adults with overweight or obesity who received once-weekly semaglutide 2.4 mg plus lifestyle intervention experienced an average body-weight reduction of 14.9% after 68 weeks, compared with 2.4% among participants who received placebo plus lifestyle intervention.
Results can vary significantly from person to person. Factors such as medical history, treatment tolerance, nutrition, physical activity, medication adherence, and duration of treatment can all influence outcomes. A healthcare provider can help determine whether semaglutide is appropriate and establish realistic expectations based on the individual patient.
Common Side Effects of Semaglutide
The most common side effects associated with semaglutide are gastrointestinal and may include nausea, diarrhea, vomiting, constipation, and abdominal discomfort. These effects are often reported during dose escalation, although severity and duration can vary from person to person. Semaglutide can also be associated with more serious risks in some patients, which is why treatment should be prescribed and monitored by a qualified healthcare provider who can review medical history, medications, and potential contraindications.
Who Should Not Take Semaglutide?
Semaglutide is not appropriate for everyone. Wegovy is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC), those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or patients with a known hypersensitivity to semaglutide or its ingredients. Other medical conditions, medications, and individual risk factors may also affect whether treatment is appropriate.
Before starting semaglutide, patients should discuss their complete medical history and current medications with a qualified healthcare provider. Medical supervision is important for evaluating potential risks, monitoring side effects, and determining whether treatment should be continued or adjusted.
Semaglutide may be an option for weight management for appropriate patients, but treatment should be based on individual health history, goals, and medical evaluation. If you’re considering Semaglutide or other prescription weight loss options, learn more about our medical weight loss program in Plano, TX and speak with a Precision Wellness Center provider to determine what may be appropriate for you.